IL148185A0 - Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction - Google Patents

Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction

Info

Publication number
IL148185A0
IL148185A0 IL14818500A IL14818500A IL148185A0 IL 148185 A0 IL148185 A0 IL 148185A0 IL 14818500 A IL14818500 A IL 14818500A IL 14818500 A IL14818500 A IL 14818500A IL 148185 A0 IL148185 A0 IL 148185A0
Authority
IL
Israel
Prior art keywords
fallopian tube
pelvic pain
chronic pelvic
endometrial tissue
therapeutic management
Prior art date
Application number
IL14818500A
Other languages
English (en)
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of IL148185A0 publication Critical patent/IL148185A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14818500A 1999-09-23 2000-09-20 Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction IL148185A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15547899P 1999-09-23 1999-09-23
PCT/EP2000/009212 WO2001021194A2 (en) 1999-09-23 2000-09-20 Method for the therapeutic management of endometriosis and fallopian tube obstruction

Publications (1)

Publication Number Publication Date
IL148185A0 true IL148185A0 (en) 2002-09-12

Family

ID=22555601

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14818500A IL148185A0 (en) 1999-09-23 2000-09-20 Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction

Country Status (22)

Country Link
EP (1) EP1214086A2 (xx)
JP (2) JP2003509467A (xx)
KR (1) KR100772852B1 (xx)
CN (2) CN101045155A (xx)
AU (1) AU769482B2 (xx)
BG (1) BG66128B1 (xx)
BR (1) BR0014198A (xx)
CA (1) CA2383510A1 (xx)
HK (1) HK1049117A1 (xx)
HU (1) HUP0202741A3 (xx)
IL (1) IL148185A0 (xx)
MX (1) MXPA02002436A (xx)
NO (1) NO331198B1 (xx)
NZ (1) NZ534836A (xx)
PL (1) PL201898B1 (xx)
RU (1) RU2255759C2 (xx)
SK (1) SK3752002A3 (xx)
TR (1) TR200200738T2 (xx)
TW (1) TWI267373B (xx)
UA (1) UA73956C2 (xx)
WO (1) WO2001021194A2 (xx)
ZA (1) ZA200201374B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10157628A1 (de) * 2001-11-26 2003-06-12 Zentaris Ag Injektionslösung eines LHRH-Antagonisten
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
PT2252627T (pt) 2008-01-24 2017-07-24 Esperance Pharmaceuticals Constructos de fusão de domínio lítico e métodos para produzir e utilizar os mesmos
EP2379099A1 (en) * 2009-01-22 2011-10-26 Maatschap Interne Geneeskunde Rijnstate Method for the prophylaxis or treatment of flushing
KR102460297B1 (ko) 2012-10-30 2022-10-28 에스퍼란스 파마슈티컬스, 인코포레이티드 항체/약물 컨쥬게이트 및 이의 사용 방법
CA2906894A1 (en) 2013-03-15 2014-09-18 Abbvie Inc. Compositions comprising elagolix for use in treating pain associated with endometriosis
WO2019036713A1 (en) 2017-08-18 2019-02-21 Abbvie Inc. SOLID PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF ENDOMETRIOSIS, UTERINE FIBROIDS, POLYKYSTIC OVARY SYNDROME AND ADENOMYOSIS
JP7374885B2 (ja) 2017-08-18 2023-11-07 アッヴィ・インコーポレイテッド 子宮内膜症、子宮筋腫、多嚢胞性卵巣症候群又は腺筋症を治療するための医薬製剤
CA3097340A1 (en) 2018-04-19 2019-10-24 Abbvie Inc. Methods of treating heavy menstrual bleeding
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
SE9301606D0 (sv) * 1993-05-07 1993-05-07 Per-Christer Oden Composition for the treatment of impaired hair growth
US5658884A (en) * 1994-07-22 1997-08-19 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
IL114655A (en) * 1994-07-22 2005-08-31 Hampton Roads Medical College USE OF GnRH ANTAGONIST IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF A GONADAL-STEROID DEPENDENT CONDITION IN A MAMMAL
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
EP0943336A1 (en) * 1996-09-04 1999-09-22 Dott Research Laboratory Peptide-containing pharmaceutical compositions for oral administration
CA2292605A1 (en) * 1997-06-05 1998-12-10 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
AU769482B2 (en) 2004-01-29
SK3752002A3 (en) 2003-06-03
WO2001021194A3 (en) 2002-03-14
HUP0202741A2 (hu) 2003-01-28
MXPA02002436A (es) 2003-02-12
HUP0202741A3 (en) 2003-12-29
CN101045155A (zh) 2007-10-03
BG66128B1 (bg) 2011-06-30
NZ534836A (en) 2007-07-27
ZA200201374B (en) 2002-10-30
EP1214086A2 (en) 2002-06-19
CN1376070A (zh) 2002-10-23
JP2012051920A (ja) 2012-03-15
KR100772852B1 (ko) 2007-11-02
TR200200738T2 (tr) 2002-08-21
PL201898B1 (pl) 2009-05-29
HK1049117A1 (zh) 2003-05-02
PL353244A1 (en) 2003-11-03
AU7779200A (en) 2001-04-24
KR20020035879A (ko) 2002-05-15
NO20021430D0 (no) 2002-03-21
RU2255759C2 (ru) 2005-07-10
CA2383510A1 (en) 2001-03-29
NO331198B1 (no) 2011-10-31
WO2001021194A2 (en) 2001-03-29
JP2003509467A (ja) 2003-03-11
BR0014198A (pt) 2002-05-21
TWI267373B (en) 2006-12-01
NO20021430L (no) 2002-05-07
BG106584A (bg) 2003-02-28
UA73956C2 (en) 2005-10-17

Similar Documents

Publication Publication Date Title
AU3734300A (en) Method and apparatus for establishing and maintaining therapeutic hypothermia
IL132760A0 (en) Vibrator for treatment of constipation
AU3968401A (en) System for warming lower extremities of supine persons
EP1404343A4 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
MY145215A (en) Vaginalli administered anti-dysrhythmic agents for treating uterine dysrhythmia
IL148185A0 (en) Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
AU2317600A (en) Pressure-pulse therapy apparatus for treatment of tissue
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
HUP0204448A3 (en) Trnasdermal therapeutic system for the delivery of lerisetron
EP1183024A4 (en) THERAPEUTIC USE OF MELATONIN
HK1048441A1 (en) Drug for treating fractures
HK1047687A1 (zh) 組織凝固的裝置
EP1171579A4 (en) TR9 HUMAN RECEPTOR OF TUMOR NECROSIS FACTORS
EP1210370A4 (en) TUMOR NECROSIS FACTOR TR16 HUMAN RECEPTOR
TW422099U (en) Spinal massage device
NZ514013A (en) Treatment of hiatial hernia
GB9912184D0 (en) Therapeutic use
GB9913350D0 (en) Therapeutic use
GB9921953D0 (en) Therapeutic use
GB9924980D0 (en) Therapeutic treatment
GB9901505D0 (en) Therapeutic treatment
GB9826888D0 (en) Cervical cancer treatment

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees